These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 311717)
21. Biphasic inhibition of bioactive hypothalamic corticotrophin releasing factor secretion in vitro by corticosterone and prevention of the second phase by various steroids. Beckford U; Holmes MC; Gillham B; Jones MT J Endocrinol; 1983 Jun; 97(3):339-46. PubMed ID: 6602859 [TBL] [Abstract][Full Text] [Related]
22. Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro. Gillies G; Puri A; Hodgkinson S; Lowry PJ J Endocrinol; 1984 Oct; 103(1):25-9. PubMed ID: 6090571 [TBL] [Abstract][Full Text] [Related]
23. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. Suda T; Yajima F; Tomori N; Demura H; Shizume K Life Sci; 1985 Oct; 37(16):1499-505. PubMed ID: 2995748 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K Life Sci; 1987 Apr; 40(17):1645-9. PubMed ID: 2882402 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat. Buckingham JC Eur J Pharmacol; 1984 Feb; 98(2):211-21. PubMed ID: 6325216 [TBL] [Abstract][Full Text] [Related]
26. Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro. Ibanez-Santos J; Tsagarakis S; Rees LH; Besser GM; Grossman A J Endocrinol; 1990 Aug; 126(2):223-8. PubMed ID: 2144872 [TBL] [Abstract][Full Text] [Related]
27. Site of action of 5-hydroxytryptophan and 5-hydroxytryptamine on the hypothalamo-pituitary-adrenal system in vitro. Telegdy G; Kardos M Acta Physiol Acad Sci Hung; 1975; 46(3):253-6. PubMed ID: 198221 [TBL] [Abstract][Full Text] [Related]
28. Dynamics of the formation and release of corticotrophin releasing activity by the rat hypothalamus in vitro. Gillham B; Beckford U; Insall RL; Skelly AM; Jones MT J Endocrinol; 1981 Aug; 90(2):201-10. PubMed ID: 6267155 [No Abstract] [Full Text] [Related]
29. Acute effects of acephate and methamidophos and interleukin-1 on corticotropin-releasing factor (CRF) synthesis in and release from the hypothalamus in vitro. Singh AK Comp Biochem Physiol C Toxicol Pharmacol; 2002 May; 132(1):9-24. PubMed ID: 12039681 [TBL] [Abstract][Full Text] [Related]
30. Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro. Tsagarakis S; Rees LH; Besser M; Grossman A Neuroendocrinology; 1990 May; 51(5):599-605. PubMed ID: 2162017 [TBL] [Abstract][Full Text] [Related]
31. Lack of effect of serotonin and norepinephrine on CRF release from hypothalami in vitro. Tate PW; Newell DC; Cook EE; Martinson DR; Hagen TC Horm Metab Res; 1983 Jul; 15(7):342-6. PubMed ID: 6309639 [TBL] [Abstract][Full Text] [Related]
32. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH. Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552 [TBL] [Abstract][Full Text] [Related]
33. The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies. Grossman A; Costa A; Navarra P; Tsagarakis S Ciba Found Symp; 1993; 172():129-43; discussion 143-50. PubMed ID: 8491084 [TBL] [Abstract][Full Text] [Related]
34. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Rivier C; Rivier J; Lee S Brain Res; 1996 May; 721(1-2):83-90. PubMed ID: 8793087 [TBL] [Abstract][Full Text] [Related]
36. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation. Tucci JR; Nowakowski KJ; Jackson IM J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391 [TBL] [Abstract][Full Text] [Related]
37. Time course study on the effect of reserpine on hypothalamic immunoreactive CRF levels in rats. Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K Brain Res; 1987 Mar; 405(2):247-52. PubMed ID: 3032352 [TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids modulate rat hypothalamic corticotrophin-releasing factor release induced by interleukin-1. Cambronero JC; Borrell J; Guaza C J Neurosci Res; 1989 Dec; 24(4):470-6. PubMed ID: 2557456 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro. Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K Endocrinology; 1986 Jan; 118(1):459-61. PubMed ID: 3000747 [TBL] [Abstract][Full Text] [Related]
40. Corticotropin-releasing factor release from in vitro superfused and incubated rat hypothalamus. Effect of potassium, norepinephrine, and dopamine. Joanny P; Steinberg J; Zamora AJ; Conte-Devolx B; Millet Y; Oliver C Peptides; 1989; 10(5):903-11. PubMed ID: 2514417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]